Molecular Characterization, Drug Resistance and Virulence Analysis of Constitutive and Inducible Clindamycin Resistance
PCR
Staphylococcus aureus
clindamycin
coagulase
methicillin-resistant Staphylococcus aureus
polymerase chain reaction
Journal
Infection and drug resistance
ISSN: 1178-6973
Titre abrégé: Infect Drug Resist
Pays: New Zealand
ID NLM: 101550216
Informations de publication
Date de publication:
2020
2020
Historique:
received:
27
02
2020
accepted:
08
04
2020
entrez:
6
5
2020
pubmed:
6
5
2020
medline:
6
5
2020
Statut:
epublish
Résumé
Macrolide-lincosamide streptogramin B family is one of the important alternative antibiotics for treating staphylococcal infections. The aim of this study was to determine the characteristics and prevalence of antibiotic resistance genes in different coagulase types of clinical In the present study, 86 isolates with different phenotypes of MLS The prevalences of constitutive MLS These findings indicated high resistance rate and low genetic variability with the prominence of
Sections du résumé
BACKGROUND
BACKGROUND
Macrolide-lincosamide streptogramin B family is one of the important alternative antibiotics for treating staphylococcal infections. The aim of this study was to determine the characteristics and prevalence of antibiotic resistance genes in different coagulase types of clinical
METHODS
METHODS
In the present study, 86 isolates with different phenotypes of MLS
RESULTS
RESULTS
The prevalences of constitutive MLS
CONCLUSION
CONCLUSIONS
These findings indicated high resistance rate and low genetic variability with the prominence of
Identifiants
pubmed: 32368106
doi: 10.2147/IDR.S251450
pii: 251450
pmc: PMC7183778
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1155-1162Informations de copyright
© 2020 Goudarzi et al.
Déclaration de conflit d'intérêts
The authors declare that they have no conflict interest.
Références
J Infect Public Health. 2017 May - Jun;10(3):316-323
pubmed: 27328777
Diagn Microbiol Infect Dis. 2007 May;58(1):125-7
pubmed: 17240103
Jundishapur J Microbiol. 2014 Dec 01;7(12):e11868
pubmed: 25741427
Antimicrob Agents Chemother. 2005 Jun;49(6):2283-8
pubmed: 15917522
Jpn J Infect Dis. 2005 Apr;58(2):104-6
pubmed: 15858290
BMC Res Notes. 2018 Oct 10;11(1):711
pubmed: 30305181
Int J Antimicrob Agents. 2012 Aug;40(2):103-7
pubmed: 22612900
Med J Armed Forces India. 2014 Jan;70(1):43-7
pubmed: 24623947
J Infect Dev Ctries. 2013 Nov 15;7(11):825-31
pubmed: 24240040
J Clin Microbiol. 2001 Sep;39(9):3115-21
pubmed: 11526138
Burns. 2012 May;38(3):378-82
pubmed: 22040930
Diagn Microbiol Infect Dis. 2016 Jun;85(2):213-7
pubmed: 27133306
Indian J Med Microbiol. 2016 Jul-Sep;34(3):350-2
pubmed: 27514959
Acta Microbiol Immunol Hung. 2012 Jun;59(2):239-47
pubmed: 22750783
Burns. 2013 Jun;39(4):650-4
pubmed: 23499497
J Antimicrob Chemother. 2000 Jun;45(6):891-4
pubmed: 10837446
Microbiol Res. 2006;161(1):49-54
pubmed: 16338590
Clin Infect Dis. 2005 Jan 15;40(2):280-5
pubmed: 15655748
Iran J Microbiol. 2014 Dec;6(6):421-7
pubmed: 25926961
Antimicrob Agents Chemother. 2010 Sep;54(9):3614-7
pubmed: 20566766
J Glob Antimicrob Resist. 2016 Mar;4:16-20
pubmed: 27436387
Jpn J Infect Dis. 2010 Jul;63(4):257-63
pubmed: 20657065
Int J Microbiol. 2014;2014:650328
pubmed: 24955091
BMC Microbiol. 2015 Oct 13;15:210
pubmed: 26463589
Clin Microbiol Rev. 2015 Jul;28(3):603-61
pubmed: 26016486
Iran J Microbiol. 2017 Oct;9(5):264-270
pubmed: 29296270
BMC Infect Dis. 2017 Jul 11;17(1):483
pubmed: 28693489
New Microbes New Infect. 2017 May 24;19:8-12
pubmed: 28663797
J Microbiol Immunol Infect. 2011 Feb;44(1):57-62
pubmed: 21531354
Int J Antimicrob Agents. 2010 Feb;35(2):114-8
pubmed: 19939636
3 Biotech. 2014 Feb;4(1):85-89
pubmed: 28324465
Indian J Med Microbiol. 2010 Apr-Jun;28(2):124-6
pubmed: 20404457
Front Cell Infect Microbiol. 2012 Feb 16;2:12
pubmed: 22919604